Global survey on molecular testing in lung cancer patients

KUALA LUMPUR, July 12 (Bernama) -- The International Association for the Study of Lung Cancer (IASLC) encourages participation from all professionals who involved in molecular testing of lung cancer patients in its global survey.



The survey is designed to assess the implementation of best practices and ultimately develop worldwide guidelines for molecular testing, a statement said.



Expert participation is critical to understanding the current status of molecular testing of the cancer as well as any regional challenges and barriers to implementation.



The IASLC, founded in 1974 also invites health care professionals and other interested parties to take part in the survey. It is available in English, Chinese, Japanese, Portuguese and Spanish.



A summary of the key findings will be shared with respondents and a full report will be submitted to the Journal of Thoracic Oncology, the official journal of the IASLC, for publication.



Respondents will be entered into a drawing to win free registration to an upcoming IASLC World Conference on Lung Cancer.



The IASLC is committed to serving as a global resource for all involved in lung cancer -- the leading cause of cancer-related deaths worldwide.



Take the survey on www.iaslc.org/survey.



--BERNAMA